MAS
58
2
A
47
6
JPM
57
-5
BBY
43
3
ROK
38
-14
UAL
80
-3
GPC
29
7
CHD
42
-3
HRL
27
-3
CFG
52
-2
CINF
37
6
IR
57
2
EQR
44
7
DVN
43
7
VMC
57
-5
FRT
36
2
OMC
59
4
RF
53
-3
EBAY
40
6
FOXA
59
7
MAS
58
2
A
47
6
JPM
57
-5
BBY
43
3
ROK
38
-14
UAL
80
-3
GPC
29
7
CHD
42
-3
HRL
27
-3
CFG
52
-2
CINF
37
6
IR
57
2
EQR
44
7
DVN
43
7
VMC
57
-5
FRT
36
2
OMC
59
4
RF
53
-3
EBAY
40
6
FOXA
59
7
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
19

BPTH
Bio-Path Holdings

Last Price:
0.90
Seasonality Move:
-15.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Bio-Path Holdings Price Quote

$0.90
-0.10 (-9.67%)
(Updated: November 5, 2024 at 5:55 PM ET)

Bio-Path Holdings Key Stats

Sell
19
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.93 - $1.00
52-week range:
$0.85 - $13.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.97%
Volume:
48K
Avg. volume:
2.4M
1-year change:
-92.02%
Market cap:
$2.5M
Revenue:
$0
EPS:
$-16.67

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $4M
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is 0.57

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.4M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.68%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 1907.43%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    212.6K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders